U.S. FDA Requirements: Diphenhydramine Hydrochloride
Pharmaceutical / Drug Definition :
Interferes with histamine effects at histamine1-receptor sites; prevents but doesn't reverse histamine-mediated response. Also possesses CNS depressant and anticholinergic properties.
FDA Label Requirements and Exceptions
Diphenhydramine Hydrochloride
FDA Import Information
Diphenhydramine Hydrochloride
FDA Detentions
Diphenhydramine Hydrochloride (Diphenhydramine Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Diphenhydramine Hydrochloride (Diphenhydramine Hydrochloride Suppliers)
- Processors Diphenhydramine Hydrochloride
- Repackers Diphenhydramine Hydrochloride
- Relabelers Diphenhydramine Hydrochloride
- Exporters Diphenhydramine Hydrochloride
- Importers Diphenhydramine Hydrochloride
For more information about Diphenhydramine Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
